A Single-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-L10D Cell Formulations Targeting CD19 and CD22 in Patients With CD19- and/or CD22-Positive Relapsed/Refractory B-cell Lymphoma

Name: A Single-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-L10D Cell Formulations Targeting CD19 and CD22 in Patients With CD19- and/or CD22-Positive Relapsed/Refractory B-cell Lymphoma
License: Public Domain

Second Affiliated Hospital of Xi'an Jiaotong University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

lymphoma

lymphoma, b-cell

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 127598
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.